Literature DB >> 14171782

ANTIBODIES TO HUMAN GROWTH HORMONE (HGH) IN HUMAN SUBJECTS TREATED WITH HGH.

J ROTH, S M GLICK, R S YALOW, S A BERSON.   

Abstract

Entities:  

Keywords:  ANTIBODIES; IMMUNOELECTROPHORESIS; IODINE ISOTOPES, DIAGNOSTIC; SOMATOTROPIN

Mesh：

Substances：

Year:  1964        PMID： 14171782      PMCID： PMC289586          DOI： 10.1172/JCI104989

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  21 in total

1.  IMMUNOASSAY OF HUMAN GROWTH HORMONE IN PLASMA.

Authors:  S M GLICK; J ROTH; R S YALOW; S A BERSON
Journal:  Nature       Date:  1963-08-24       Impact factor: 49.962

2.  Immunoassay of plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  Diabetes       Date:  1961 Sep-Oct       Impact factor: 9.461

3.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

4.  Species-specificity of human antibeef, pork insulin serum.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

5.  Studies on the rheumatoid and related serum factors. I. Autoimmunization of rabbits with gamma globulin.

Authors:  F MILGROM; E WITEBSKY
Journal:  JAMA       Date:  1960-09-03       Impact factor: 56.272

6.  Human growth hormone. A preliminary report.

Authors:  P H HENNEMAN; D H HENNEMAN
Journal:  Diabetes       Date:  1960 Jul-Aug       Impact factor: 9.461

7.  Evidence for the insulin-directed specificity of rabbit anti-insulin serum.

Authors:  E R ARQUILLA; A B STAVITSKY
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

8.  Preparation and properties of growth hormone from human and monkey pituitary glands.

Authors:  C H LI; H PAPKOFF
Journal:  Science       Date:  1956-12-28       Impact factor: 47.728

9.  An immunological investigation of human pituitary growth hormone.

Authors:  T HAYASHIDA; C H LI
Journal:  Science       Date:  1958-11-21       Impact factor: 47.728

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808
View more
  10 in total

1.  Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.

Authors:  H Guyda; H Friesen; J D Bailey; G Leboeuf; J C Beck
Journal:  Can Med Assoc J       Date:  1975-06-07       Impact factor: 8.262

2.  Treatment with human growth hormone (Li) for over eight years--effects of long-term therapy in a pituitary dwarf.

Authors:  R F Escamilla; P H Forsham
Journal:  Calif Med       Date:  1971-12

3.  Dwarfism.

Authors: 
Journal:  Indian J Pediatr       Date:  1968-01       Impact factor: 1.967

4.  Incidence and effects on growth of antibodies to human growth hormone.

Authors:  S R Chalkley; J M Tanner
Journal:  Arch Dis Child       Date:  1971-04       Impact factor: 3.791

Review 5.  Endocrine secretion in vitro: prolactin.

Authors:  E M Rivera; R H Kahn
Journal:  In Vitro       Date:  1970

6.  Hypopituitary dwarfism.

Authors:  G H Newns
Journal:  Proc R Soc Med       Date:  1967-07-07

7.  Spontaneously occurring anti-PTH autoantibodies must be considered in the differential diagnosis of patients with elevated serum PTH levels.

Authors:  B Cavaco; V Leite; M M Loureiro; M F Ferreira; M C Pereira; M A Santos; L G Sobrinho
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

8.  An evaluation of antibodies and clinical resistance to salmon calcitonin.

Authors:  F R Singer; J P Aldred; R M Neer; S M Krane; J T Potts; K J Bloch
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

9.  Responsiveness of growth hormone-deficient children to human growth hormone. Effect of replacement therapy for one year.

Authors:  D Rudman; J H Patterson; D L Gibbas
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

10.  Coupling Complete Blood Count and Steroidomics to Track Low Doses Administration of Recombinant Growth Hormone: An Anti-Doping Perspective.

Authors:  Luca Narduzzi; Corinne Buisson; Marie-Line Morvan; Alexandre Marchand; Michel Audran; Yves Le Bouc; Emmanuelle Varlet-Marie; Magnus Ericsson; Bruno Le Bizec; Gaud Dervilly
Journal:  Front Mol Biosci       Date:  2021-06-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.